Boundless Bio
across most patients with gene amplified tumors derive little benefit from targeted therapies | Boundless Bio
Company
Deck Type
IPO
Deck date
March 2024
Slide
12 of 51
Related slides by other companies
Investor Presentation
October 2022
Investor Presentation
November 2023
IPO
September 2020
SPAC
August 2021
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io